On the other hand, epithelial differentiation marker involucrin in OECM-1 cells with greater HK2 loss (clone C) was highly detected (Figure 4G), further supporting that HK2 change could regulate stemness and differentiation status, which modulate treatment sensitivity in HNSCC cells. Here, HK2 is linked to head and neck squamous cell carcinoma.